Assessing the value of a new pharmaceutical - O'Brien, Bernie J.; Centre for Health Economics and Policy Analysis (McMaster University, 1996)
Bernie O'Brien ... [et al.].
Includes bibliographical references (p. 25-28).
Keywords: Cost-Benefit Analysis; Economics, Pharmaceutical; Feasibility Studies; Granulocyte Colony-Stimulating Factor; Managed Care Programs; Neoplasms; drug therapy; Patient Acceptance of Health Care; Relative Value Scales